Company / Operating Income
FILANA THERAPEUTICS, INC. Operating Income History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$31.4M
FY2015
5-year range
-$13.7M / $31.4M
FY2011-FY2015
Trend
+904.8%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed +905% YoY in FY2015, a notable deviation from the 4-year average annual change of +216%.
Based on SEC 10-K filings.
$31M in FY2015.
Improved from -$4M to $31M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, operating income increased 904.8% year-over-year.
- Lowest operating income in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score 3.76 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $31.4M | +904.8% |
| FY2014 | -$3.9M | -10.9% |
| FY2013 | -$3.5M | +74.4% |
| FY2012 | -$13.7M | -102.9% |
| FY2011 | -$6.8M | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026